0001140361-11-021199.txt : 20110406
0001140361-11-021199.hdr.sgml : 20110406
20110406213402
ACCESSION NUMBER: 0001140361-11-021199
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110404
FILED AS OF DATE: 20110406
DATE AS OF CHANGE: 20110406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhang Ian
CENTRAL INDEX KEY: 0001500329
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33650
FILM NUMBER: 11744531
MAIL ADDRESS:
STREET 1: C/O NEOSTEM, INC.
STREET 2: 420 LEXINGTON AVENUE, SUITE 450
CITY: NEW YORK
STATE: NY
ZIP: 10170
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeoStem, Inc.
CENTRAL INDEX KEY: 0000320017
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 222343568
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE
STREET 2: SUITE 450
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: 212-584-4171
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE
STREET 2: SUITE 450
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE
DATE OF NAME CHANGE: 20030819
FORMER COMPANY:
FORMER CONFORMED NAME: CORNICHE GROUP INC /DE
DATE OF NAME CHANGE: 19951117
FORMER COMPANY:
FORMER CONFORMED NAME: FIDELITY MEDICAL INC
DATE OF NAME CHANGE: 19951025
4
1
doc1.xml
FORM 4
X0303
4
2011-04-04
0
0000320017
NeoStem, Inc.
NBS
0001500329
Zhang Ian
C/O NEOSTEM, INC.
420 LEXINGTON AVENUE, SUITE 450
NEW YORK
NY
10170
0
1
0
0
See Remarks
Stock Options (right to buy)
1.74
2011-04-04
4
A
0
250000
0
A
2021-04-03
Common Stock, par value $0.001 per share
250000
250000
D
On April 4, 2011, the reporting person was granted a stock option to purchase 250,000 shares of Common Stock, pursuant and subject to the terms and conditions of the 2009 Non-U.S. Plan. This stock option is scheduled to vest as to 125,000 shares on each of October 4, 2011 and April 4, 2012. The option is subject to all of the terms and conditions of the 2009 Non-U.S. Plan.
President and Managing Director, NeoStem (China), Inc.
Ian Zhang, By: /s/ Catherine M. Vaczy, Esq., Attorney-in-Fact
2011-04-06